---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-018244"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:25:03.383694+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Inogen Q1 2022 revenue down 7.5% YoY to $80.4M; net loss $0.62 per share

## Summary
- GAAP net loss $14.2M ($0.62/share); adjusted loss per share $0.39.
- Revenue $80.4M, down 7.5% YoY, up 5.2% sequentially; domestic B2B fell 83.4% to $5.1M.
- Gross margin declined 240 bps to 43.5% due to higher materials costs and temporary manufacturing shutdown.
- No FY2022 revenue guidance; Q2 revenue expected to improve sequentially and be in line with Q2 2021; expects continued losses.
- EU MDR submission for portable oxygen concentrators filed and under review.

## SEC filing metadata
- accession: 0001564590-22-018244
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000156459022018244/0001564590-22-018244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000156459022018244/ingn-8k_20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-018244
- JSON: https://secwatch.observer/filing/0001564590-22-018244.json
- Plain text: https://secwatch.observer/filing/0001564590-22-018244.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.